May 15, 2016
Pharmaceutical Technology
Collaboration and single-use technologies aided the rapid scale-up of Ebola vaccine manufacturing
May 10, 2016
By Pharmaceutical Technology Editors
Phase I clinical trials of PfSPZ revealed it may protect healthy adults, who have not been exposed to Malaria before, for more than on year.
May 04, 2016
By Pharmaceutical Technology Editors
MilliporeSigma expands its Carlsbad, California-based GMP capacity for viral and gene-therapy products by nearly 90%.
Apr 20, 2016
Traditional methods of measuring the effectiveness of vaccines against the flu are called into question by new findings from the NIH.
Apr 04, 2016
Even though the organizers of New York’s Tribeca Film Festival decided not to air the anti-vaccine film by discredited British researcher Andrew Wakefield, the so-called documentary is getting a healthy run and further perpetuating the myth of a link between childhood vaccination and autism.
Apr 02, 2016
Pharmaceutical Technology
Global outbreaks energize vaccine R&D and drive production modernization.
Mar 22, 2016
By Pharmaceutical Technology Editors
The Human Vaccines Project brings together academic research centers, industrial partners, nonprofit organizations, and governments to address the primary scientific barriers to developing new vaccines and immunotherapies.
Mar 18, 2016
By Pharmaceutical Technology Editors
During a clinical trial of 48 participants, 100% of those that received the TV003 vaccine were protected from infection.
Feb 11, 2016
Vaccine R&D has grown exponentially in recent years, spurred by ethical and medical needs to combat lethal infectious outbreaks and increased funding from public and private agencies and organizations.
Dec 03, 2015
By Pharmaceutical Technology Editors
Seqirus, CSL Limited’s influenza vaccine business, announced the opening of their corporate headquarters in the United Kingdom.
lorem ipsum